Aalzen de Haan

2.5k citations

66 papers · 1.9k indexed · h-index 25

Immunology top 5%
- Immune Cell Function and Interaction 14
- Immune Response and Inflammation 13
- Immunotherapy and Immune Responses 11
- T-cell and B-cell Immunology 7
Transplantation top 5%
Epidemiology top 5%
- Respiratory viral infections research 15
- Influenza Virus Research Studies 14
Infectious Diseases top 5%
Rheumatology top 5%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 8
Genetics
- Diabetes and associated disorders 6

Co-authors: Jan Wilschut Tjarko Meijerhof Anke Huckriede Johanna Westra Marc Bijl Sander van Assen Albert Holvast Muhammad Shafique
Cited by: Immunology Transplantation Epidemiology
Journals: Vaccine (10 papers)Transplantation (7 papers)Cell Transplantation (5 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Aalzen de Haan

64 papers receiving 1.9k citations

Peers

Countries citing papers authored by Aalzen de Haan

Since Specialization

Citations

This map shows the geographic impact of Aalzen de Haan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aalzen de Haan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aalzen de Haan more than expected).

Fields of papers citing papers by Aalzen de Haan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aalzen de Haan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aalzen de Haan. The network helps show where Aalzen de Haan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aalzen de Haan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aalzen de Haan Line = papers co-authored together Aalzen de Haan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Trypsin diminishes the rat potency of polio serotype 3 Biologicals ·Rimko ten Have,Janny Westdijk,Christopher Francis Britto,Kitagawa Kazumaro,Aalzen de Haan,Martin Hamzink,Bernard Metz,Gideon Kersten	2015	4
2	Monoclonal paraprotein influences baseline B-cell repertoire diversity and perturbates influenza vaccination-induced B-cell response Experimental Hematology ·Sarah M. Tete,David Kipling,Johanna Westra,Aalzen de Haan,Marc Bijl,Deborah K. Dunn‐Walters,Surinder S. Sahota,Nicolaas A. Bos	2015	6
3	Inactivated influenza vaccine adjuvanted with Bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion Vaccine ·Chantal Keijzer,Bert Jan Haijema,Tjarko Meijerhof,Alvama Pattiserlihun,Aalzen de Haan,Kees Leenhouts,Maarten L. van Roosmalen,Willem van Eden,Femke Broere	2014	36
4	A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats Influenza and Other Respiratory Viruses ·L. Gmelin,Toon Stegmann,Tjarko Meijerhof,Jan Wilschut,Aalzen de Haan	2013	19
5	Critical Role of TLR7 Signaling in the Priming of Cross-Protective Cytotoxic T Lymphocyte Responses by a Whole Inactivated Influenza Virus Vaccine PLoS ONE ·Natalija Budimir,Aalzen de Haan,Tjarko Meijerhof,H. Sauer,Louis Boon,Emma Gostick,David A. Price,Jan Wilschut,Anke Huckriede	2013	27
6	Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine Journal of Controlled Release ·Harshad P. Patil,吴仪 WU Yi,Wouter ter Veer,Tjarko Meijerhof,Aalzen de Haan,Henderik W. Frijlink,Jan Wilschut,Wouter L.J. Hinrichs,Anke Huckriede	2013	48
7	Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses PLoS ONE ·Muhammad Shafique,Tjarko Meijerhof,Jan Wilschut,Aalzen de Haan	2013	40
8	Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency Clinical Immunology ·Sander van Assen,Aalzen de Haan,Albert Holvast,Gerda Horst,Francois Tetero,Johanna Westra,Cees G. M. Kallenberg,Denise Telgt,A.M. Palache,Эркинов Ш. Б.,Marc Bijl	2011	22
9	Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation Vaccine ·Toon Stegmann,L. Gmelin,Tjarko Meijerhof,M. E. Bromberg,Aalzen de Haan,Jan Wilschut	2010	45
10	Rat Pancreatic β Cells and Cytomegalovirus Infection Pancreas ·Maaike J. Smelt,Marijke M. Faas,Bart J. de Haan,Suryakant Ojha,Surendra J. Patel,Romy Rigattieri,Aalzen de Haan,Paul de Vos	2009	6
11	Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis Annals of the Rheumatic Diseases ·Albert Holvast,Aalzen de Haan,Sander van Assen,Coen A. Stegeman,Minke G. Huitema,Anke Huckriede,C. A. Benne,Johanna Westra,A.M. Palache,Jan Wilschut,C. G. M. Kallenberg,Marc Bijl	2009	14
12	Antibody and cell-mediated responses to influenza vaccination in patients with systemic lupus erythematosus and, healthy controls Data Archiving and Networked Services (DANS) ·Albert Holvast,Sander van Assen,Aalzen de Haan,Anke Huckriede,Jan Wilschut,Heui-su Ryu,Johanna Westra,Cees G. M. Kallenberg,A.M. Palache,Muhammet Furkan Karakaya	2008	0
13	Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling PLoS Pathogens ·Felix Geeraedts,Nadège Goutagny,Veit Hornung,Martina Severa,Aalzen de Haan,Judith G. Pool,Jan Wilschut,Katherine A. Fitzgerald,Anke Huckriede	2008	190
14	Integrity of Airway Epithelium Is Essential Against Obliterative Airway Disease in Transplanted Rat Tracheas The Journal of Heart and Lung Transplantation ·Ning Qu,Paul de Vos,Лілія Бабінець,Aalzen de Haan,Wim Timens,Jochum Prop	2005	23
15	Skeletal muscle from molecules to movement : a textbook of muscle physiology for sport, exercise, physiotherapy and medicine Data Archiving and Networked Services (DANS) ·F. Simoncini,Jonathan Round,Aalzen de Haan	2004	11
16	Individual Human Serum Differs in the Amount of Antibodies with Affinity for Pig Fetal Ventral Mesencephalic Cells and the Ability to Lyse These Cells by Complement Activation Cell Transplantation ·Renaud Hage,Aalzen de Haan,Lin Shouyuan,Bernardina T.F. van der Gun,Henk van Dijk,Jan Rozing,Lou de Leij,Michiel J. Staal	2004	5
17	Detection of alloreactive T cells by flow cytometry: a new test compared with limiting dilution assay1 Transplantation ·Aalzen de Haan,Bernardina T.F. van der Gun,Wim van der Bij,Lou F. M. H. de Leij,Jochum Prop	2002	13
18	Het effect van FES-fiets training bij een dwarslaesie VU Research Portal ·H.L. Gerrits,Aalzen de Haan,Biyong Cheng,H. van Langen,Maria T. E. Hopman	2000	1
19	DECREASED DONOR-SPECIFIC CYTOTOXIC T CELL PRECURSOR FREQUENCIES ONE YEAR AFTER CLINICAL LUNG TRANSPLANTATION DO NOT REFLECT TRANSPLANTATION TOLERANCE: A COMPARISON OF LUNG TRANSPLANT RECIPIENTS WITH OR WITHOUT BRONCHIOLITIS OBLITERANS SYNDROME1 Transplantation ·Aalzen de Haan,Bernardina T.F. van der Gun,Bouke G. Hepkema,W.J. de Boer,Wim van der Bij,Lou F. M. H. de Leij,Jochum Prop	2000	15
20	Donor-specific immunological non-responsiveness after liver transplantation Transplant International ·Aad P. van den Berg,Aalzen de Haan,GARETH A. OWENS,К. Dzedzic,E. van Twuyver,I. J. Klompmaker,Kostantinos Skevis,Leo P. de Waal,M. J. H. Slooff,T H Thé	1998	4

About Aalzen de Haan

Aalzen de Haan is a scholar working on Transplantation, Immunology, Epidemiology, Complementary and Manual Therapy and Radiology, Nuclear Medicine and Imaging, having authored 66 papers that have together received 1.9k indexed citations. Recurring topics across this work include Respiratory viral infections research (15 papers), Influenza Virus Research Studies (14 papers), Immune Cell Function and Interaction (14 papers), Immune Response and Inflammation (13 papers), Immunotherapy and Immune Responses (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (7 papers) and Diabetes and associated disorders (6 papers). The work is most often cited by research in Immunology (770 citations), Transplantation (68 citations), Epidemiology (753 citations), Infectious Diseases (380 citations) and Rheumatology (211 citations). Aalzen de Haan has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jan Wilschut, Tjarko Meijerhof, Anke Huckriede, Johanna Westra, Marc Bijl, Sander van Assen, Albert Holvast, Muhammad Shafique, Cees G. M. Kallenberg and C. A. Benne. Their work appears in journals such as Vaccine, Transplantation, Cell Transplantation, PLoS ONE and Pancreas.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact